Joeky Senders

82 Chapter 4 20. Dickinson H, Carico C, Nuno M, et al. Unplanned readmissions and survival following brain tumor surgery. Journal of neurosurgery. 2015;122(1):61-68. 21. Nabi S, Kahlon P, Bozorgnia F, Arshad A, Mikkelsen T, Donthireddy V. Predictors of Venous Thromboembolism in Patients with Glioblastoma. Pathology oncology research : POR. 2016;22(2):311- 316. 22. Rodas RA, Fenstermaker RA, McKeever PE, et al. Correlation of intraluminal thrombosis in brain tumor vessels with postoperative thrombotic complications: a preliminary report. Journal of neurosurgery. 1998;89(2):200-205. 23. Misch M, Czabanka M, Dengler J, et al. D-dimer elevation and paresis predict thromboembolic events during bevacizumab therapy for recurrent malignant glioma. Anticancer research. 2013;33(5):2093-2098. 24. Streiff MB. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Cancer-Associated Venous Thromboembolic Disease. Version 1.2014. In: National Comprehensive Cancer Network; 2014. 25. Farge D, Bounameaux H, Brenner B, et al. International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer. Lancet Oncol. 2016;17(10):e452-e466. 26. Lyman GH, Bohlke K, Khorana AA, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014. J Clin Oncol. 2015;33(6):654-656. 27. Farge D, Debourdeau P, Beckers M, et al. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. Journal of thrombosis and haemostasis : JTH. 2013;11(1):56-70. 28. Strangman D. Clinical Practice Guidelines for the management of adult gliomas: astrocytomas and oligodendrogliomas. In: Cancer Council Australia/Australian Cancer Network/Clinical Oncological Society of Australia; 2009. 29. Guyatt GH, Akl EA, Crowther M, et al. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):7S-47S. 30. Carman TL, Kanner AA, Barnett GH, Deitcher SR. Prevention of thromboembolism after neurosurgery for brain and spinal tumors. South Med J. 2003;96(1):17-22. 31. Zwicker JI, Karp Leaf R, Carrier M. A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation. Journal of thrombosis and haemostasis : JTH. 2016;14(9):1736- 1740. 32. Senders JT, Goldhaber NH, Cote DJ, et al. Venous thromboembolism and intracranial hemorrhage after craniotomy for primary malignant brain tumors: a National Surgical Quality Improvement Program analysis. Journal of neuro-oncology. 2017. 33. Mantia C, Uhlmann EJ, Puligandla M, Weber GM, Neuberg D, Zwicker JI. Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin. Blood. 2017;129(25):3379- 3385. 34. Al Megren M, De Wit C, Al Qahtani M, Le Gal G, Carrier M. Management of venous thromboembolism in patients with glioma. Thrombosis research. 2017;156:105-108.